Mavoglurant (AFQ056)

DRUG2 trials

Sponsors

Yale University

Conditions

Familial Alcoholism Vulnerability

Early Phase 1

Metabotropic Glutamate Receptor-5 (mGlur5) Effects on Reward-Related fMRI-BOLD Activation in FHP and FHN

CompletedNCT03341715

Yale UniversityFamilial Alcoholism Vulnerability

Start: 2018-06-01End: 2019-11-13Updated: 2022-01-11

Functional Neuroimaging of Alcoholism Vulnerability: Probing Glutamate and Reward, Using the mGluR5 Inhibitor Mavoglurant

RecruitingNCT05203965

Yale UniversityFamilial Alcoholism Vulnerability

Start: 2022-05-17End: 2026-07-31Target: 80Updated: 2025-10-09